VS: BP 165/90, P 98, RR 18, T 37 C; waist circ 38 in, Wt 240 lbs (109 kg), Ht 5'8''

Similar documents
Complete this CE activity online at ProCE.com/InsulinPart2

Topic: Chronic Heart Failure Cases for Monday s March 21th lecture.

Case Studies in T2DM A Comprehensive Management Approach

Reason for referral: provide patient education on management of hypoglycemia and glucose monitor

Advanced Pharmacology Diabetes Homework

It Happens Even in Type 2! When to Start Thinking Seriously About Hypoglycemia

CHALLENGING CASE PRESENTATION Steroid Induced Hyperglycemia

A Practical Approach to the Use of Diabetes Medications

Type 2 Diabetes Performance Improvement Initiative: Chart Reviews. Lara Zisblatt Boston University School of Medicine Boston, MA

Participants in the Program

Patient is a 60 YO MALE seen in clinic for diabetes management follow-up. Allergies/ADEs: FLUNISOLIDE, PRIMIDONE, ALEVE CAPLET, CARBAMAZEPINE

PHYSICIANS INTERACTIVE PARTICIPANT GUIDE

2/4/13. Insulin Dosing. Insulin Dosing. Insulin Dosing. Insulin Dosing. Insulin Dosing. Insulin Dosing

Appendix A: Sample Patient Profiles and Prescriptions

Welcome Everyone. Monitoring, Sick Days, Inpatient Management - Objectives. Mrs. Jones has new diabetes. She asks you: Page 1

Diabetes: Use of Adjunctive Therapy ACEs, ARBs, ASA & STATINs --Oh My! Veronica J. Brady, PhD, FNP-BC, BC-ADM, CDE Project ECHO April 19, 2018

Primary Care Patient Case Example

HEALTH BEHAVIOR CHANGE: CASE DISCUSSIONS IN NUTRITION A M Y L O C K E, M D, F A A F P, A B I H M

RISK FACTORS OR COMPLICATIONS AND RECOMMENDED TREATMENT GOALS AND FREQUENCY OF EVALUATION FOR ADULTS WITH DIABETES

Doctor s Instructions Patient: Mr Abdul Shareef Age: 40. Last Consultation Dr Mitchell 2 weeks ago

Objectives. Objectives. Alejandro J. de la Torre, MD Cook Children s Hospital May 30, 2015

Application of the Diabetes Algorithm to a Patient

Does Adding Examples to the American Society of Anesthesiologists Physical Status Classification Improve Consistency in Assignment to Patients?

51 year old woman with hyperglycemia. August 9, 2012 Katie Stanley, MD

Clinical Cases in Diabetes Management. Joseph Cook D.O.

Disclosures. Diabetes and Cardiovascular Risk Management. Learning Objectives. Atherosclerotic Cardiovascular Disease

Clinical Approach to Achieving Treatment Targets: Case Vignette Discussion

Topic: Chronic Heart Failure Cases for Monday s March 21th lecture.

2018 SNPhA/Kroger National Clinical Skills Competition Charlotte, NC Division I

Special thanks to the EJC Foundation for their support of Sanford Center Geriatric Specialty Clinic

9/28/2012. Sponsored By: NDSU College of Pharmacy, Nursing and Allied Sciences

Diabetes and Heart Disease Awareness. Washington Newsletter Fall 2011

Breaking the Cycle: Using Incretin-Based Therapies to Overcome Clinical Inertia in Type 2 Diabetes

Here are a few ideas to help you cope and get through this learning period:

Type 2 Diabetes Mellitus Insulin Therapy 2012

Individualizing Care for Patients with Type 2 Diabetes

A 45 year old African American man presents to the IMC with a chief complaint of my

Metabolic Syndrome. Shon Meek MD, PhD Mayo Clinic Florida Endocrinology

Diabetes Mellitus Type 2

Challenges in type 2 diabetes control: slipping control and weight gain

The Diabetes Link to Heart Disease

Treat-to-Target Tools

TEAMcare Treat-to-Target Tools

Diabetes. HED\ED:NS-BL 037-3rd

2017 SNPhA/Kroger Clinical Skills National Competition: Las Vegas, NV: DIVISION II

Case Discussions: Treatment Strategies for High Risk Populations. Most Common Reasons for Referral to the Baylor Lipid Clinic

Management of Diabetes New Concepts New Devices New Medications. Richard J. Comi, MD Professor of Medicine Geisel School of Medicine at Dartmouth

Heart Healthy Living Tips

Basal-Bolus Insulin Therapy. Veronica Brady, PhD, FNP-BC, BC-ADM, CDE ECHO January

Wayne Gravois, MD August 6, 2017

CASE-BASED SMALL GROUP DISCUSSION

PRESS RELEASE. November is Diabetes Awareness Month Severity/Epidemic and Risk Factors of Diabetes

Standard Medicare and Managed Medicare plans pay for diabetes education.

8/5/2017. Disclosure to Participants. Learning Outcomes. Terry Compton MS, APRN, CDE. Seniors with Diabetes: Why Are They Different?

Reducing ASCVD Risk Focus on Lipids. Carol Marsh, DNP, APRN, CNP, FPCNA Clinical Lipid Specialist

Real Life Approaches to Optimal Diabetes Care for the Busy Practitioner

Nutrition Packet INFORMATION FOR THE DAY OF YOUR APPOINTMENT

Disclosures. Objectives. Cardiovascular Risk. Patient Case. JUPITER: The final frontier in statin utilization or an idea from outer space?

Evaluating the Cardiovascular Benefits of Antidiabetic Medications

Piedmont Healthcare Endocrinology

Case study: Adult with uncontrolled type 2 diabetes of long duration and cardiovascular disease

Conflict of Interest Disclosure. Learning Objectives. Learning Objectives. Guidelines. Update on Lifestyle Guidelines

21 INSTRUCTOR GUIDELINES

CASE-BASED SMALL GROUP DISCUSSION MHD II SESSION VI

11/4/2014. Outline. Pharmacists Objectives. Diabetes Update: What s New in Pharmacy Technician Objectives. Overview: Type 2 Diabetes Mellitus

Diabetes Mellitus Case Study

Type 1 Diabetes Mellitus in the Adult. Katie Davis & Liz DeJulius KNH 411: Medical Nutrition Therapy I

Heart Healthy Living Tips

Rev. date Kaiser Foundation Health Plan of Washington

Screening for diabetes

Progression of Diabetes Medication Addition

SESSION 5 - Cardiovascular

DIABETES SELF MANAGEMENT EDUCATION / NUTRITION COUNSELING INITIAL ASSESSMENT. NAME Today s Date

Helping You Manage Your Diabetes

STANDARDS OF MEDICAL CARE IN DIABETES 2014

APhA March 2016 Annual Meeting Obesity Cases

Clinical Practice Guideline Key Points

ABFM Diabetes SAM Part 4

Living Well with Diabetes. Meeting 12. Welcome!

External Examiner: Miss C Biggs Internal Examiner: Mrs S Ogilvie DURATION: 3 HOURS TOTAL MARKS: 150

Date of Birth. Black/African American. What is your occupation? Retired? Yes No

What is Diabetes Mellitus?

WELL-WOMAN EXAM REVEALS RISK. Katie Jones, MPH, CHES Iowa Department of Public Health Erin Hinderaker, MS, RD, LD Des Moines University

Learning Objectives. Outline 4/3/2018. Treatment Strategies to Maximize the Value of Diabetes Medications

Executive Summary Report Sample Executive Report Page 1

DKA Adult ICU Powerplan

Insulin Initiation, titration & Insulin switch in the Primary Care-KISS

Insulin Optimisation Workshop. Theingi Aung & Claire Rowell

Joslin Diabetes Center Joslin Diabetes Forum 2013: The Impact of Comorbidities on Glucose Control Scenario 2: Reduced Renal Function

American Diabetes Association: Standards of Medical Care in Diabetes 2015

Journal Club September 29, Vanessa AKIKI PGYlII Internal Medicine

Diapression: Recognizing and Effectively Treating Depression in Individuals with Diabetes

TUE Physician Guidelines Medical Information to Support the Decisions of TUE Committees Diabetes Mellitus DIABETES MELLITUS

Diagnosis of Seasonal and Pandemic Influenza. Objectives. Influenza Infections 11/7/2014

MHD I SESSION X. Renal Disease

Carbamazepine has a clearance of L/h/kg for monotherapy. For immediate release carbamazepine, the oral bioavailbility is 0.8

Patient: Becky Smith DOB: 01/26/XXXX Age: 5 y/o Attending: Dr. D. Miles Allergies: NKA MR#: 203. Patient Chart #203 Becky Smith

Keeping your diabetes support as mobile as you are,

Rick Fox M.A Health and Wellness Specialist

DIABETES COMPLICATIONS PROMPT DECK. stack the deck. against diabetes complications

Transcription:

IMC Didactic Case-Diabetes Mellitus Chief Complaint "I was recently diagnosed with diabetes and would like to have my blood sugar tested. I think that my blood sugar is running low because I have the shakes and a terrible headache. HPI: Sarah Martin is a 43-year-old woman who comes to the pharmacy for a diabetes education class taught by the pharmacist. She would like for the pharmacist to check her blood sugar before the class begins. She was diagnosed with diabetes mellitus Type 2 about 6 months ago. She has been attempting to control her disease with diet and exercise but has had no success. Her physician has recently started her on glyburide 5 mg. She has gained 15 lb over the past year. She monitors her blood sugar once a day, per her physician, with a range of 215 260 mg/dl. Her fasting blood sugars average 170 mg/dl. She took her glyburide this morning but didn t have time to eat breakfast. PMH: Type 2 DM x 6 months HTN x 15 years Asthma x 20 years Dyslipidemia x 10 years Morbid obesity x 15 years FH: Father has history of HTN. Mother has a history of dyslipidemia. Brother has DM secondary to alcoholism. SH: Has been married for 21 years. She has two children who are teenagers. She works in a floral shop making deliveries. She does have limited medical/prescription insurance through her husband s factory job. She smokes ½ pack per day of cigarettes (down from 1 pack per day 6 months ago) and drinks alcohol occasionally (five beers/wine per week). Meds: Glyburide 5 mg po BID Lisinopril 20 mg po once daily Advair 250mg/50mg 1 puff BID Fluoxetine 20 mg po Q AM EC ASA 81 mg po once daily Pravastatin 40 mg po once daily All: Morphine hives ROS: Complains of nocturia, polyuria, and polydipsia on a daily basis. Denies nausea, constipation, diarrhea, signs or symptoms of hypoglycemia, paresthesias, and dyspnea. Physical Examination: severely obese, Caucasian woman in NAD, R and L fundus exam without retinopathy. Lungs- clear breath sounds, no wheezing or cyanosis. Cardiac- RRR, no MRG. Extremities- femorals, popliteals, and right dorsalis pedis pulses 2+ throughout; left dorsalis pedis 3+; feet show mild calluses on MTPs, feet with normal sensation (5.07 monofilament) and vibration VS: BP 165/90, P 98, RR 18, T 37 C; waist circ 38 in, Wt 240 lbs (109 kg), Ht 5'8''

Labs Na 139 meq/l Ca 9.4 mg/dl Fasting Lipid Profile: K 3.6 meq/l Phos 3.3 mg/dl T. chol 236 mg/dl Cl 103 meq/l AST 15 IU/L LDL 135 mg/dl CO2 31 meq/l ALT 18 IU/L HDL 56 mg/dl BUN 15 mg/dl Alk Phos 62 IU/L Trig 223 mg/dl SCr 0.8 mg/dl T. bili 0.4 mg/dl TC/HDL ratio 4.2 Gluc (random) 74 mg/dl Hg A1c 9.8% UA 1+ protein, (+) microalbuminuria Assessment: The patient reports that she exercises at most once a week and her diet is difficult to maintain due to the nature of her job as a delivery person. Her glycemic control has been maintained with an 8.9% Hg A1c 6 months ago. She has had a moderate weight gain of 15 lb (6.8 kg) over the past year. Her blood pressure and cholesterol are not at goal on the current drug therapy. Please utilize the following resources in order to determine the appropriate management for Mrs. Martin s worsened DM. 1) What do the 2013 American Diabetes Association (ADA) guidelines say about initiation of therapy in patients with Type 2 Diabetes Mellitus? (http://care.diabetesjournals.org/content/36/supplement_1/s11.full) - Page S22 (http://care.diabetesjournals.org/content/36/supplement_1/s4.full.pdf+html) - Page S5

2) What concerns and risks exist regarding the use of glyburide with regard to side effects and efficacy as monotherapy? (http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a56f100f-0f42-4188-81ab- 04644b824040) http://online.lexi.com/lco/action/home/switch?siteid=202 3) In order to follow the ADA guidelines, you decide to discontinue therapy with glyburide and initiate metformin therapy. What dose should Mrs. Martin be started on? How should dose titration be approached and why? What monitoring is necessary in patients on metformin therapy? (dose, monitoring and literature to support starting this) http://online.lexi.com/lco/action/home/switch?siteid=202 4) It has been three months since Mrs. Martin began a steady dose of metformin 1000mg BID. She presents to the IMC for a follow-up visit and her Hg A1c today is now at 8.2%. Per the 2013 ADA guidelines, you decide to initiate a second oral agent. What would you choose to initiate and why? ADA Guidelines for hyperglycemia managementhttp://care.diabetesjournals.org/content/early/2012/04/17/dc12-0413.full.pdf+html Pg 1370-1373

5) Since the initiation and maximization of a second oral agent, Mrs. Martin has had to pick up more overnight flower delivery shifts to pay for vehicle damages that occurred while teaching her oldest child to drive. In order to stay awake, she starts drinking one or two Monster energy drinks a night and frequently snacks on Sweet Tarts during her deliveries. After cancelling her previously scheduled follow-up visit five weeks ago, she returns to the IMC for an overdue DPV. It has been 19 weeks since her last visit and she has gained 10 lbs. since then (now 264 lbs). She admits that she is often so tired that she tends to forget to take her medications and has a difficult time making healthy dietary choices. Her Hg A1c is 10.8 today. You ask about her exercise habits and she exclaims, Nobody has time for that!. You decide to initiate insulin therapy. What methods for insulin therapy exist? How should insulin therapy be initiated in Mrs. Martin? (http://www.aafp.org/afp/2011/0715/p183.html) Pg 184-186 6) Mrs. Martin understands the consequences of poorly managed diabetes and agrees to your recommendation to begin intensive insulin therapy and self-monitoring of blood glucose (SMBG). How would you educate Mrs. Martin on insulin injections and SMBG with respect to frequency and technique? How should she respond to low blood sugar readings? Some glucometer information and comparisons (http://www.diabetesadvocacy.com/glucometers.htm) Patient information on managing hypoglycemia. There is also a hard copy of this book in the IMC (http://www.diabetes.org/living-with-diabetes/treatment-and-care/blood-glucosecontrol/hypoglycemia-low-blood.html) Guidelines on SMBG http://care.diabetesjournals.org/content/36/supplement_1/s11.full.pdf+html pg- S17

7) Mrs. Martin leaves the IMC ready to tackle the challenge of taking control of her diabetes. After running a few errands, she stops at the pharmacy that evening to pick up her new insulin and diabetic testing supplies. She is shocked when she hears the price and heads home without picking up the prescriptions. When she gets home, her husband reluctantly admits that he was laid off from his job a week ago and that the family is now without health insurance. The next morning, she calls in to the IMC to report her inability to afford her insulin and testing supplies. What resources are available through the IMC to help with affordability? 8) After working with the IMC staff, Mrs. Martin is happy to report that she is experiencing significant success with her new insulin regimen. She is highly encouraged to live a healthier life and wants to know what the recommendations are to assist with proper management. What goals and recommendations should Mrs. Martin be aware of? When should follow-up visits be scheduled and what testing (including referrals) is necessary? (http://care.diabetesjournals.org/content/36/supplement_1/s11.full) - Page S24 (http://care.diabetesjournals.org/content/36/supplement_1/s4.full.pdf+html) - Page S1-S7 Case by: Michelle Cudnik, PharmD. Last updated April 2013